British scientists have industrialized the process of genomic sequencing during the pandemic, cutting the time and cost needed to generate a unique genetic fingerprint for each coronavirus case analyzed. But now researchers at the Sanger Institute in Cambridge and labs around the UK have a new mission: sharing what they've learned with other scientists.